Biofrontera Kicks Off US Clinical Study Program for Ameluz®
November 16, 2021 09:03 ET
|
Biofrontera Inc.
WOBURN, MA, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (the “Company”), a biopharmaceutical company specializing in the commercialization of dermatological products, announced...